| 摘要 |
<p>5,14-Dihydrobenz[5,6]isoindolo[2,1-b]isoquinotine-8,13-dione
<Chemistry id="chema01" num="0001"><Image id="ia01" he="29" wi="84" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /></Chemistry>exhibits anticancer activity. The compound can be prepared by reaction of 2-formyl-3-carboxyl-1,2,3,4-tetrahydroisoquinoline with 1,4-naphthoquinone and is particularly suitably administered parenterally in microcrystalline suspension form.</p> |
